Government gives green light to CNB: Genetically modified virus to fight against COVID-19

Royal Decree 8/2020 has approved various and extraordinary measures, including authorization to the National Biotechnology Centre (CNB) to use any genetically modified organism (GMO) they believe appropriately to combat the SARS-CoV-2 (COVID-19) pandemic.

The EMA & The FDA co-presede the first regulatory workshop on Covid-19 for vaccine development

Yesterday 18th of March, 2020, the first global regulatory workshop on COVID-19, was convened under the umbrella of the International Coalition of Medicines Regulatory Authorities (ICMRA).

AEMPS publishes recommendations during the crisis period by COVID-19 in Spain

Exceptional measures applicable to clinical trials to manage problems arising from the COVID-19 emergency